Cargando…
A Case of Idiopathic Central Serous Chorioretinopathy in a 12-year-old Male Treated with Bevacizumab
A 12-year-old male presented with a chief complaint of a 1-month-history of decreased visual acuity in his right eye. The patient had no past history of steroid use or other systemic diseases. On fundus examination, which included fluorescent angiography (FAG) and optical coherence tomography (OCT),...
Autores principales: | Kim, Yu Cheol, Kim, Si Dong, Kim, Kwang Soo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Ophthalmological Society
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3464325/ https://www.ncbi.nlm.nih.gov/pubmed/23060728 http://dx.doi.org/10.3341/kjo.2012.26.5.391 |
Ejemplares similares
-
Presumed Idiopathic Central Serous Chorioretinopathy in a 12-Year-Old Girl
por: Velazquez-Martin, Juan P., et al.
Publicado: (2012) -
Intravitreal Bevacizumab for Treatment of Central Serous Chorioretinopathy
por: Ünlü, Cihan, et al.
Publicado: (2016) -
The Effect of Intravitreal Bevacizumab on Central Serous Chorioretinopathy
por: Maleki, Alireza, et al.
Publicado: (2018) -
The Effect of Intravitreal Bevacizumab in Patients with Acute Central Serous Chorioretinopathy
por: Lim, Ji Won, et al.
Publicado: (2010) -
The Association between Choroidal Thickness Variations and Response to Intravitreal Bevacizumab in Central Serous Chorioretinopathy
por: Kim, Dong Yoon, et al.
Publicado: (2015)